Crossmark

PCT-to-albumin ratio and CRP-to-albumin ratio as predictors of febrile neutropenia complications: a prospective observational trial

Published Online: 2025-03-10

Published Print: 2025-04

Authors

Dimitrijević, Jelena

Čalamać, Marina

Đurmez, Ognjen

Stojanović, Marko https://orcid.org/0000-0003-2097-7591
Funding

Funding for this research was provided by:

Ministry of Education, Science and Technological Development of Republic of Serbia (Grant number 451-03-9/2021-14/200110 and 175023)
License Information

Text and Data Mining valid from 2025-03-10

Version of Record valid from 2025-03-10
More Information

Article History

Received: 4 January 2024

Accepted: 3 March 2025

First Online: 10 March 2025

Declarations

:

: This study was performed in line with the principles of the Declaration of Helsinki. The ethical approval was obtained from the Ethical Committee of Institute for Oncology and Radiology of Serbia/National Cancer Research Center (no. 1184–01) and Ethical Committee of Medical Faculty, University of Belgrade (no. 1322/VII-15).

: Informed consent was obtained from all individual participants included in the study.

: The authors declare no competing interests.

Document is current